lakepharma.comfilesEventsLakePharma Symposium 2019LakePharma Symposium 2019 Banner

 

Agenda

(Subject to change)

8:00 - 8:50 AM Registration and Breakfast
   
8:55 - 9:00 AM Welcome Remarks by Hua Tu, Ph.D., CEO of LakePharma
   
9:00 - 9:35 AM

Session 1
A Platform for Identifying Strategies for Reversing Cancer and Restoring the Immune Response

Dean Felsher

Dean Felsher, MD, Ph.D.
Director of Oncology Research, Director of Translational Research and Applied Medicine at Stanford University

   
9:40 - 10:15 AM

Session 2
Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy

Dave_Schafer

David Schaffer, Ph.D.
Director of the Berkeley Stem Cell Center at UC Berkeley

   
10:20 - 10:40 AM Break
   
10:45 - 11:20 AM

Session 3
Industrializing the Manufacture of Cell and Gene Therapies

Madhusudan Peshwa

Madhusudan Peshwa, Ph.D.
Chief Technology Officer at Global Cell Therapy at GE Healthcare

   
11:25 - 12:00 PM

Session 4
Comparison of Baculovirus (BV)-Sf9 and HEK293 Expression Systems for the Production of Adeno-Associated Viral (AAV) Vectors

Michael Boychyn

Michael Boychyn, Ph.D.
Vice President of Process Development at REGENXBIO Inc.

   
12:00 - 1:15 PM Lunch in Baden Room A and B
   
12:40 - 1:10 PM

Parallel Lunch Workshops

Workshop 1: Panel Discussion on Cell Therapy GMP Manufacturing
Sponsored by LakePharma | Salon A Room | View Abstract

Workshop 2: Alt-R CRISPR Genome Editing: Innovation Driving Solutions for HDR, Specificity, and Off-Target Analysis
Sponsored by Integrated DNA Technologies, Inc. | Salon B Room | View Abstract

Workshop 3: Expanding SPR Throughput Orders of Magnitude to Accelerate Therapeutic Antibody Discovery
Sponsored by Carterra | Salon C Room | View Abstract

Workshop 4: Integrated Workflow Solutions for Development of Cellular Therapies
Sponsored by Thermo Fisher Scientific | Salon D Room | View Abstract

   
1:15 - 1:20 PM Brief Remarks by Norm Garceau, Ph.D., VP, Technical Operations, LakePharma
   
1:20 - 1:55 PM

Session 5
Synthetic Lethal Approaches to Cancer Therapy

Alan Ashworth

Alan Ashworth, Ph.D., FRS
President of Helen Diller Family Comprehensive Cancer Center at UCSF

   
2:00 - 2:35 PM

Session 6
Clinical and Pre-Clinical Approaches Using T Regulatory Cells to Prevent or Treat Graft-versus-Host Disease

Everett Meyer

Everett Meyer, MD, Ph.D.
Medical and Scientific Director, Cellular Therapy Facility at Stanford University

   
2:35 - 3:00 PM Poster Break
   
3:05 - 3:40 PM

Session 7
The Combination of Immune Cells and Oncolytic Virus Creates A Unique Multi-mechanistic Biotherapy for Treatment of Refractory Solid Tumors  

Pam-Contag

Pamela Contag, Ph.D.
CEO, BIoeclipse

   
3:45 - 4:20 PM

Session 8
From CRO to CRDMO, LakePharma's Technology Development in Meeting Next-Generation Therapeutic Needs

Hua Tu_cropped 2

Hua Tu, Ph.D.
CEO, LakePharma

   
4:30 - 5:30 PM Happy Hour and Networking

 

Posters

"Accelerating advancement in gene therapy by improving downstream purification of viral vectors"
Wendy Chan  |  Thermo Fisher Scientific
  "A Novel Matrix Insensitive Platform for Measuring Ligand Binding Interactions"
Heng Yu  |  MagArray
     
"LakePharma's Hybridoma-Based Antibody Discovery to Support CAR T Development"
Ashlee Zheng  |  LakePharma

  "Generation and Validation of A Diverse VHH Phage Display Library from Naive Llamas"
Hoa Giang  |  LakePharma
     
"Discovery and Validation of Functional Anti-FOLR1 Antibodies with AbTheneum"
Allison Schulkins  |  Single Cell Technology
  "Structure-Guided Molecular Cloning for Improving Site-Directed Mutagenesis and Stability in Protein Design"
Thomas Leary  |  DNASTAR
     
"Selection Strategies to Identify Unique Hits Against G-Protein Coupled Receptors"
Emily Sever  |  Twist Bioscience
  "Assessment of Two Different Selection Strategies to Identify IgG Against GLP1R"
Erica Keane  |  Twist Bioscience
     
"Closed and Automated Cell Processing Using Rotea to Advance Cell Therapy"
Mark Landon  |  Thermo Fisher Scientific
  "A PD-1 Therapy That Elevates Treg/Th Balance and Increases Tumor Cell pSmad3 to Promote Durable Rejection and Immunity in Squamous Cell Carcinomas"
Eswari Dodagatta-Marri  |  UCSF
     
"A Simplified Workflow for Monoclonal Antibody Sequencing"
Lena Meyer  |  UC Santa Cruz
  "Novel Reporter-Based Bioassays for Evaluating FcgR-Dependent Functions of Therapeutic Antibodies"
Neal Cosby  |  Promega
     
"Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors"
Jay Amin  |  Promega
  "Closed and Automated Cell Processing Using Rotea to Advance Cell Therapy"
Mark Landon  |  Thermo Fisher Scientific
     
"The New Hound: Three Lasers to ID it All"
Donna Chen  |  Unchained Labs
  "Plug into Fast, Accurate Protein Quantification with Lunatic"
Dina Finan  |  Unchained Labs
     
"Multispecific Antibody Development Using Sequence-Based Discovery of Human Heavy Chain Antibodies"
Nicole Allen  |  Teneo Bio
  "Rapid Purification, Conjugation and Proteolysis of Antibodies Using High Capacity Capturem Membranes"
Christian Hoppmann  |  Takara Bio
     
"An Adherent and Scalable Platform for the Production of Viral Vectors"
Calista Ng  |  BioPharmEquip 
 

 

 


Return to 2019 LakePharma Symposium Main Page >>